Blockchain

Dune Becomes the Most Comprehensive Onchain Data Hub for Polkadot’s 50+ Parachains

Boston, Mass, September 11th, 2024, Chainwire

 

New Integration Expands Dune’s Coverage Across the Entire Polkadot Ecosystem, Delivering Unmatched Onchain Analytics

Zurg, Switzerland, September 11th 2024 Dune, the leading platform for onchain analytics, announces the integration of 50+ parachains from the Polkadot ecosystem. With this expansion, Dune solidifies its position as the most comprehensive data hub for Polkadot, offering unparalleled insights and analytics for developers, investors, and data enthusiasts alike.

Earlier this year, Dune launched support for Polkadot, Kusama, and six parachains. Now, the platform takes a major step forward by expanding coverage to include the entire Polkadot ecosystem. This integration enables users to explore, analyze, and visualize all onchain activities across Polkadot in real time, making Dune the go-to destination for data-driven decision-making.

Polkadot’s ecosystem, known for its diverse and innovative parachains, generates a vast amount of data. Navigating this complex network can be a challenge. Dune’s expanded support simplifies access to crucial onchain data, empowering users to gain deeper insights into Polkadot’s dynamic ecosystem.

The newly integrated parachains include Moonbeam, which specializes in smart contracts and cross-chain DeFi; Acala, known as Polkadot’s hub for decentralized finance; Phala, which focuses on privacy-first DePIN and AI solutions; and Mythos, a protocol bringing AAA decentralized gaming and hugely popular franchises to Polkadot. These integrations, along with dozens of others, position Dune as the most expansive source for Polkadot’s onchain analytics, allowing users to track transaction flows, analyze DeFi activity, and monitor developments in gaming and NFTs—all within a single, comprehensive platform.

FredrikHaga, CEO of Dune shared, “Polkadot and its Substrate-based chains form a vast and complex ecosystem. With this integration of 50+ parachains, our goal is to make that complexity easier to navigate. We want to give people a clear, accessible view of what’s happening across the network, so they can focus on innovation and building with confidence.”

This milestone integration was achieved through Dune’s partnership with Colorful Notion. Together, the teams developed a streamlined process for integrating new parachains, ensuring Dune’s data remains comprehensive, accurate, and reliable.

Dune’s integration also includes enhanced functionality through the Dune API, allowing users to convert any query into a flexible API endpoint. This feature offers greater flexibility for developers and analysts, enabling them to seamlessly incorporate Dune’s data into their own applications.

To learn more about the latest Polkadot integrations, readers can visit Dune’s Polkadot Analytics.

About Dune 

Dune is a leading data analytics platform that democratizes access to onchain data by enabling users to query, visualize, and share insights across various blockchains. With over 700,000 community-contributed data tables, Dune supports comprehensive analysis of tokens, wallets, protocols, and more. The platform’s recent launch of the Dune API extends its capabilities for automated reporting, alerting, and integration into user applications.

For more information, readers can visit https://dune.com/home

About Polkadot

Polkadot is the powerful, secure core of Web3, providing a shared foundation that unites some of the world’s most transformative apps and blockchains. Polkadot offers advanced modular architecture that allows devs to easily design and build their own specialized blockchain projects, pooled security that ensures the same high standard for secure block production across all connected chains and apps connected to it, and robust governance that ensures a transparent system where everyone has say in shaping the blockchain ecosystem for growth and sustainability. With Polkadot, you’re not just a participant, you’re a co-creator with the power to shape its future.

 

Contact

Jonathan Duran
jonathan@distractive.xyz

PostAd_coinrule_banner728x90

Leave a Comment

Your email address will not be published. Required fields are marked *

*

Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection

2024-09-17T13:00:00Z

Assessment by specialist AI team from “PersonalAIze” Highlights the Strength, Potential, and Visionary Talent Behind the Innovative Software as a Service (SaaS) Platform

AMSTERDAM, Sept. 17, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: RENB) - PersonalAIze, a cutting-edge company in AI and machine learning applications for healthcare, has conducted a comprehensive evaluation of RenovaroCube’s advanced AI platform. This effort is spearheaded by PersonalAIze CEOs and AI experts, Mark Hoogendoorn and Sandjai Bhulai, who bring their extensive expertise to assess the platform developed under the guidance of Frank van Asch, CTO and co-Founder of the technology on which RenovaroCube is based.

Prof. Mark Hoogendoorn, also a professor of Artificial Intelligence, expressed his enthusiasm: “We were pleased to be engaged to make an assessment of the AI platform; this is exactly the area of PersonalAIze’s expertise.”

Frank van Asch remarked on the collaboration, “The expertise of PersonalAIze’s team is exceptional, and their positive evaluation of our AI/ML platform is invaluable.”

RenovaroCube's AI platform has been advancing innovation for the past 12 years, evolving from its award-winning Fintech roots into a potentially groundbreaking multi-omic molecular differential system that identifies cancer in its earliest stages. It is an open platform that can be used as a SaaS by many private sector and academic or other large hospital and health systems. It is also disease agnostic, so it can be expanded for many purposes.

The initial aim is to transform cancer early detection and early detection of recurrence from a small vial of blood (liquid biopsy), potentially supporting clinicians to initiate treatments as soon as possible towards improved outcomes for patients.

In their analysis, PersonalAIze noted the platform's focus on liquid biopsies and third-generation sequencing coupled with AI techniques as highly promising, potentially allowing for comprehensive analysis across varying cancer types and stages. Prof. Sandjai Bhulai, also a professor of Mathematics, commented on the platform’s unique potential and the impressive multidisciplinary team at RenovaroCube under Frank van Asch’s leadership.

Based on these findings, PersonalAIze is eager to collaborate further with RenovaroCube to enhance and commercialize the platform.

PersonalAIze aims to contribute in several key areas:

  • Advancing AI models by leveraging the latest state-of-the-art techniques.
  • Supporting the professional growth of the software team.
  • Enhancing the explainability of AI models, engaging clinicians in model development.
  • Selecting optimal patient groups for data collection and evaluating models and final products in clinical settings.

This partnership could represent a substantial step forward in the fight against cancer, bringing together AI innovation and healthcare expertise to develop a powerful tool for early detection that has the potential to save countless lives.

About Renovaro
Renovaro aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. Renovaro Inc. includes RenovaroBio with its advanced cell-gene immunotherapy company and RenovaroCube.

RenovaroCube has developed an award-winning AI platform that is committed to the early detection of cancer and its recurrence and monitoring subsequent treatments. RenovaroCube intervenes at a stage where potential therapy can be most effective. RenovaroCube is a molecular data science company with a background in FinTech and a 12-year history. It brings together proprietary artificial intelligence (AI) technology, multi-omics, multi-modal data, and the expertise of a carefully selected multidisciplinary team to radically accelerate precision medicine and enable breakthrough changes in cancer care.

About PersonalAIze
PersonalAIze focusses on building solutions that improve healthcare by leveraging state-of-the-art AI techniques. It has been founded by four experienced professors bringing together decades of research experience in AI and healthcare with the aim to bring the latest scientific AI developments into healthcare practice faster. PersonalAIze does this through both consultancy and product development and targets clinical decision making systems as well as improvement of health care operations such as capacity planning.

Forward-Looking Statements

Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties, including but not limited to the success or efficacy of our pipeline, platform and fundraising. All statements other than historical facts are forward-looking statements, which can be identified by the use of forward-looking terminology such as “believes,” “plans,” “expects,” “aims,” “intends,” “potential,” or similar expressions. Actual events or results may differ materially from those projected in any of such statements due to various uncertainties, including as set forth in Renovaro’s most recent Annual Report on Form 10-K filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Renovaro Inc. undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.

For media inquiries, please contact: karen@renovarocube.com

Source: Renovaro Inc.


GlobeNewsWire News

Recent Comments